John Ireland, PA
Physician Assistant · Williamsburg, VANPI 1881166312
Payments from drug & device makers
Across 117 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$540
- Lilly USA, LLC$351
- Radius Health, Inc.$264
- AbbVie$241
- Dexcom, Inc.$151
- Boehringer Ingelheim$127
- plus $768 from 16 others
What the payments were for
- Food & beverage$2,442100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 14 | $540 |
| Lilly USA, LLC | 17 | $351 |
| Radius Health, Inc. | 18 | $264 |
| AbbVie | 12 | $241 |
| Dexcom, Inc. | 8 | $151 |
| Boehringer Ingelheim | 6 | $127 |
| AstraZeneca | 8 | $127 |
| Novo Nordisk | 7 | $119 |
| Amneal Pharmaceuticals LLC | 7 | $115 |
| Mannkind Corporation | 4 | $75 |
| Sequel Med Tech, LLC | 2 | $47 |
| BETA Bionics, Inc. | 2 | $46 |
| Amgen(2 entities) | 2 | $42 |
| Medtronic | 2 | $30 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Pfizer | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Cequr Corporation | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
| Boston Scientific | 1 | $13 |
How this compares
$2,442 in reported general payments places this provider in the 85th percentile of 3,376 physician assistant providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 107 | $173,696 |
| TrulicityDulaglutide | 79 | $108,558 |
| JardianceEmpagliflozin | 58 | $77,311 |
| MounjaroTirzepatide | 37 | $63,698 |
| FarxigaDapagliflozin Propanediol | 61 | $42,261 |
| JanuviaSitagliptin Phosphate | 30 | $40,672 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 13 | $36,128 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 34 | $28,612 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 24 | $21,078 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 19 | $18,416 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 77 | $16,943 |
| Novolog FlexpenInsulin Aspart | 23 | $10,586 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 12 | $10,536 |
| SynthroidLevothyroxine Sodium | 97 | $7,277 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $6,120 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Insulin Lispro | $351 | $174,614138 claims |
| Novo NordiskOzempic | $119 | $173,696107 claims |
| Boehringer IngelheimJardiance | $127 | $77,31158 claims |
| AstraZenecaFarxiga | $127 | $42,26161 claims |
| AbbVieSynthroid | $241 | $7,27797 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $115 | $3,088202 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Williamsburg
- Amanda WaggonerWilliamsburg$12K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- John CarterStaunton$90K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
- Hillary HartungNorfolk$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.